Propolis nasal spray effectively improves recovery from infectious acute rhinitis and common cold symptoms in children: a pilot study / (Record no. 13110)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02326nas a22002657a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20210421161430.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m|||||r|||| 00| 0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | ta |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 171219t2017 sp ||||| |||| 00| 0 spa | |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0393-974X |
040 ## - CATALOGING SOURCE | |
Transcribing agency | Salus Infirmorum |
245 00 - TITLE STATEMENT | |
Title | Propolis nasal spray effectively improves recovery from infectious acute rhinitis and common cold symptoms in children: a pilot study / |
Statement of responsibility, etc. | Marti J; López F; Gascón I; Julve J |
500 ## - GENERAL NOTE | |
General note | PDF en biblioteca |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Bibliografía: 949-950 |
520 8# - SUMMARY, ETC. | |
Summary, etc. | Currently, treatment for acute rhinitis (AR) is symptomatic but no clear agreement exists to control its development. Propolis extract may appear as a promising natural treatment for AR, but its beneficial effects have not yet been fully tested. Forty children suffering from AR and common cold symptoms aged between 2-12 years were enrolled in a prospective epidemiological multicentre study. A 7-day treatment with propolis nasal spray (3 times/day) was applied and a comparison of symptomatology, subjective global improvement and quality of life (QoL) between baseline (day 1) and final (day 7) visits were performed. The main goal was to evaluate the changes in symptom intensity using the Jackson’s scoring test. After 7 days of treatment there was a significant decrease of symptoms both in the total score (p < 0.0001) and in regard to each AR symptom (p < 0.01). On the whole, the sample reported no symptoms by day 7, and the resolution of symptoms occurred approximately at day 4. Furthermore, there was no <br/>need for supplementary treatment. Both the subjective global improvement impression and the QoL of patients appeared to significantly improve after treatment. No adverse events (AEs) were found globally. <br/>It can be concluded that propolis nasal spray effectively improves recovery from infectious AR and common cold symptoms in children and is an optimal alternative in the treatment of this disease without need for any adjuvant treatment. |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | propolis |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | acute rhinitis |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | cold |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | effectiveness |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | quality of life |
653 14 - INDEX TERM--UNCONTROLLED | |
Uncontrolled term | children |
773 ## - HOST ITEM ENTRY | |
Related parts | -- 2017, v. 31, 4, p. 943-950 |
Title | Journal of biological regulators and homeostatic agents |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Universal Decimal Classification |
Koha item type | Artículo de revista |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Universal Decimal Classification | Non-fiction | Revistas y artículos | Revistas y artículos | 21/04/2021 | PP | 5751 | 21/04/2021 | 21/04/2021 | Artículo de revista |